Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(38%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
5
63%
Ph phase_2
1
13%
Ph phase_4
2
25%

Phase Distribution

5

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(5)

Detailed Status

Completed5
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (62.5%)
Phase 21 (12.5%)
Phase 42 (25.0%)

Trials by Status

recruiting338%
completed563%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_2

BPL-1357 Against H1N1 Influenza Virus Challenge

NCT07215858
recruitingphase_1

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

NCT06408857
recruitingphase_4

The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes

NCT06982183
completedphase_1

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

NCT04826094
completedphase_1

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

NCT05437289
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07215858Phase 2

BPL-1357 Against H1N1 Influenza Virus Challenge

Recruiting
NCT06408857Phase 1

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

Recruiting
NCT06982183Phase 4

The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes

Recruiting
NCT04826094Phase 1

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Completed
NCT05437289Phase 1

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Completed
NCT01986010Phase 1

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

Completed
NCT01877642Phase 4

ADASUVE-Lorazepam Drug-Drug Interaction

Completed
NCT00439335Phase 1

Higher Dose Intradermal H5 Vaccine

Completed

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8